Clinical Trial Update: A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase II/Phase 1-2 trial evaluating the efficacy and safety of sivelestat in adults with acute lung injury and acute respiratory distress syndrome; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Sivelestat (sivelestat)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Respiratory Distress Syndrome, Adult, Acute Lung Injury | Phase 1, Phase 2 | Status: COMPLETED